KOREA WHO
-
-
Chairman of Amicogen
Shin Yong-chul
Microbiology Professor-Turned-Entrepreneur Starts Bio Company to Create Jobs for Students
-
Last Updated on Aug 27, 2024
-
Chairman of Amicogen
Copy Url : https://www.koreawho.com/profile/ShinYongchul- Life Summary
Shin Yong-chul is the founder and chairman of Amicogen. He also serves as the chairman of the board of directors.
He was born on August 4, 1960.
He graduated from Seoul National University with a degree in Food Engineering and earned both his master's and doctoral degrees in Biotechnology from KAIST.
Shin Yong-chul was a professor in the Department of Microbiology at Gyeongsang National University. During the IMF financial crisis, he decided to start a business to create jobs as his students struggled with employment difficulties.
In 2000, he founded the biotech venture company "Amicogen" in Jinju, Gyeongnam, where Gyeongsang National University is located.
Amicogen operates in the healthcare industry by utilizing special enzyme technology developed in-house.
Amicogen's eco-friendly special enzymes play a role in reducing environmental pollutants by about 30% during the production process of synthetic drugs.
The company also manufactures and sells health functional foods using its special enzyme technology.
After 25 years since its founding, Shin Yong-chul is recognized as a successful professor-turned-entrepreneur, having grown Amicogen to a market capitalization of around KRW 300 billion (US$ 217.8 million).
#ShinYongchul #Amicogen #biotechnology #enzyme #healthcare #eco-friendly #startups #professor #entrepreneur #IMFcrisis
He was born on August 4, 1960.
He graduated from Seoul National University with a degree in Food Engineering and earned both his master's and doctoral degrees in Biotechnology from KAIST.
Shin Yong-chul was a professor in the Department of Microbiology at Gyeongsang National University. During the IMF financial crisis, he decided to start a business to create jobs as his students struggled with employment difficulties.
In 2000, he founded the biotech venture company "Amicogen" in Jinju, Gyeongnam, where Gyeongsang National University is located.
Amicogen operates in the healthcare industry by utilizing special enzyme technology developed in-house.
Amicogen's eco-friendly special enzymes play a role in reducing environmental pollutants by about 30% during the production process of synthetic drugs.
The company also manufactures and sells health functional foods using its special enzyme technology.
After 25 years since its founding, Shin Yong-chul is recognized as a successful professor-turned-entrepreneur, having grown Amicogen to a market capitalization of around KRW 300 billion (US$ 217.8 million).
#ShinYongchul #Amicogen #biotechnology #enzyme #healthcare #eco-friendly #startups #professor #entrepreneur #IMFcrisis
